0001209191-23-021743.txt : 20230330 0001209191-23-021743.hdr.sgml : 20230330 20230330210435 ACCESSION NUMBER: 0001209191-23-021743 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230328 FILED AS OF DATE: 20230330 DATE AS OF CHANGE: 20230330 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mancini Marianna CENTRAL INDEX KEY: 0001838112 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37355 FILM NUMBER: 23782665 MAIL ADDRESS: STREET 1: C/O VIKING THERAPEUTICS, INC. STREET 2: 12340 EL CAMINO REAL, STE 250 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Viking Therapeutics, Inc. CENTRAL INDEX KEY: 0001607678 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 461073877 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9920 PACIFIC HEIGHTS BLVD, SUITE 350 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-704-4660 MAIL ADDRESS: STREET 1: 9920 PACIFIC HEIGHTS BLVD, SUITE 350 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-03-28 0 0001607678 Viking Therapeutics, Inc. VKTX 0001838112 Mancini Marianna C/O VIKING THERAPEUTICS, INC. 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 0 1 0 0 Chief Operating Officer 0 Common Stock, par value $0.00001 per share 2023-03-28 4 M 0 15000 2.15 A 332273 D Common Stock, par value $0.00001 per share 2023-03-28 4 M 0 4873 1.88 A 337146 D Common Stock, par value $0.00001 per share 2023-03-28 4 M 0 15000 1.26 A 352146 D Common Stock, par value $0.00001 per share 2023-03-28 4 M 0 53054 1.23 A 405200 D Common Stock, par value $0.00001 per share 2023-03-28 4 M 0 15000 1.08 A 420200 D Common Stock, par value $0.00001 per share 2023-03-28 4 M 0 10000 1.04 A 430200 D Common Stock, par value $0.00001 per share 2023-03-28 4 M 0 24500 4.65 A 454700 D Common Stock, par value $0.00001 per share 2023-03-28 4 M 0 30000 4.37 A 484700 D Common Stock, par value $0.00001 per share 2023-03-28 4 S 0 196563 15.00 D 288137 D Common Stock, par value $0.00001 per share 2023-03-29 4 M 0 15000 9.13 A 303137 D Common Stock, par value $0.00001 per share 2023-03-29 4 S 0 41242 16.00 D 261895 D Stock Option (right to buy) 2.15 2023-03-28 4 M 0 15000 0.00 D 2017-03-04 2026-03-04 Common Stock 15000 0 D Stock Option (right to buy) 1.88 2023-03-28 4 M 0 4873 0.00 D 2016-03-14 2026-03-14 Common Stock 4873 0 D Stock Option (right to buy) 1.26 2023-03-28 4 M 0 15000 0.00 D 2017-06-30 2026-06-30 Common Stock 15000 0 D Stock Option (right to buy) 1.23 2023-03-28 4 M 0 53054 0.00 D 2017-01-05 2027-01-05 Common Stock 53054 0 D Stock Option (right to buy) 1.08 2023-03-28 4 M 0 15000 0.00 D 2018-06-30 2027-06-30 Common Stock 15000 0 D Stock Option (right to buy) 1.04 2023-03-28 4 M 0 10000 0.00 D 2018-08-31 2027-08-31 Common Stock 10000 0 D Stock Option (right to buy) 4.65 2023-03-28 4 M 0 24500 0.00 D 2019-01-19 2028-01-19 Common Stock 24500 0 D Stock Option (right to buy) 4.37 2023-03-28 4 M 0 30000 0.00 D 2019-03-30 2028-03-30 Common Stock 30000 0 D Stock Option (right to buy) 9.13 2023-03-29 4 M 0 15000 0.00 D 2016-05-21 2025-05-21 Common Stock 15000 0 D The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person. 25% of the shares subject to the option vested on each one year anniversary of the grant date. The shares subject to the option vested on the grant date. 23,054 shares vested on the grant date of 01/05/2017 and 25% of the remaining 30,000 shares subject to the option vested on each one year anniversary of the grant date. One-third of the shares subject to the option vested on each one year anniversary of the grant date. /s/ Michael Morneau as Attorney-in-Fact 2023-03-30